Curevo Vaccine Revenue and Competitors
Estimated Revenue & Valuation
- Curevo Vaccine's estimated annual revenue is currently $7.8M per year.
- Curevo Vaccine's estimated revenue per employee is $155,000
Employee Data
- Curevo Vaccine has 50 Employees.
- Curevo Vaccine grew their employee count by 35% last year.
Curevo Vaccine Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $0.9M | 6 | 0% | N/A | N/A |
#2 | $0.9M | 6 | 0% | N/A | N/A |
#3 | $5.1M | 33 | 6% | N/A | N/A |
#4 | $5.7M | 37 | 42% | N/A | N/A |
#5 | $1.4M | 18 | -10% | N/A | N/A |
#6 | $3.7M | 48 | -21% | $16M | N/A |
#7 | $1.1M | 7 | 0% | N/A | N/A |
#8 | $0.8M | 5 | -81% | N/A | N/A |
#9 | $2.5M | 16 | -27% | N/A | N/A |
#10 | $0.8M | 5 | -17% | N/A | N/A |
What Is Curevo Vaccine?
Curevo will combine excellence in protein science and adjuvant technology to speed safe and highly effective vaccines from the bench through clinical development. Curevo will focus on vaccine-preventable illnesses that are common in both the Asian and US markets and for which current vaccine products are not available. Curevo’s goal is to rapidly advance innovative new vaccine candidates from research laboratory to clinic by joining forces with South Korean Mogam Institute for Biomedical Research, GC Pharma, and the Infectious Disease Research Institute based in Seattle, Washington.
keywords:N/A
N/A
Total Funding
50
Number of Employees
$7.8M
Revenue (est)
35%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Seattle
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $6M | 50 | 0% | N/A |
#2 | $8.8M | 50 | 28% | N/A |
#3 | $5.8M | 50 | N/A | N/A |
#4 | $8.6M | 50 | -12% | N/A |
#5 | $7.6M | 50 | 6% | N/A |